In this respect, the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/mTOR/Akt pathways represent key therapeutic targets as they are often dysregulated by various mutations in cancer and these cascades control the activities of many proteins critical for cell growth and metastasis. Here, RAF1 is linked to cancer.